Irritable bowel syndrome (IBS) is frequently misdiagnosed, masking serious conditions like ovarian cancer, endometriosis, and bile acid diarrhea that require entirely different treatments. At the fifth edition of IBS Days in Bologna, Italy, held from June 15 to 17, 2026, researchers presented alarming evidence that IBS-like symptoms can be a red flag for other diseases, and that understanding the gut microbiome offers new ways to distinguish between conditions and develop targeted therapies.

Why Are Doctors Confusing IBS With Other Diseases?

The overlap between IBS and other conditions is surprisingly common. Women with endometriosis have a pooled prevalence of IBS in 23.4% of cases, yet the two diseases involve different underlying mechanisms. More concerning, women under 50 who receive an IBS diagnosis face a 7% increased hazard ratio for undiagnosed ovarian cancer, according to research presented at the conference. National Institute for Health and Care Excellence guidelines now recommend that doctors perform appropriate tests for ovarian cancer in any woman aged 50 or older who has experienced IBS-like symptoms within the past 12 months.

IBS also frequently co-occurs with inflammatory bowel disease (IBD). Approximately 30% of IBD patients, particularly those with Crohn's disease, report IBS-like symptoms even when their intestinal inflammation is in remission. Additionally, about 10% of people develop IBS following a gastrointestinal infection, suggesting that post-infectious changes to the gut barrier and immune system may be driving symptoms rather than true IBS.

A global study of over 54,000 adults across 26 countries revealed that when disorders of gut-brain interaction overlap across multiple regions of the digestive tract (esophageal, gastroduodenal, bowel, and anorectal), disease severity and quality of life decline significantly. Female sex and gender-related factors also influence how these conditions present and which comorbidities develop.

What Role Does the Gut Barrier Play in IBS?

Recent research highlights that the gut barrier is not a single structure but a four-part system composed of the gut microbiota, mucus layer, epithelial barrier, and vascular barrier. Elevated intestinal permeability, or a "leaky gut," is common in children and adults with IBS, especially in the diarrhea and post-infectious subtypes. This increased permeability may arise from damage to both the epithelial and vascular barriers and directly contributes to clinical symptoms.

Emerging findings suggest a previously unknown secondary protective mechanism. When the gut vascular barrier becomes compromised during inflammation, such as during gastroenteritis, a choroid plexus vascular barrier in the brain activates as a backup defense against systemic inflammation. Understanding these layered barriers opens new therapeutic avenues for protecting the gut and brain.

How to Restore Gut Barrier Function

Experts at IBS Days presented multiple evidence-based strategies for repairing intestinal permeability and supporting the microbiome:

• Dietary fiber increase: Complex soluble fibers such as pectin and beta-glucan support mucus production and maintain gut barrier homeostasis, whereas diets low in fiber and high in emulsifiers (carboxymethylcellulose and polysorbate 80), saturated fats, and salt impair intestinal permeability and promote pathogenic bacteria growth.
• FODMAP reduction: When appropriate, reducing fermentable carbohydrates (FODMAPs) may improve colonic barrier dysfunction and reduce mast cell activation in patients with IBD-related diarrhea.
• Targeted nutraceuticals: Sodium butyrate, glutamine, blends of prebiotics with pea protein and grape seed extract, and selected probiotics show promise in restoring both epithelial and vascular barriers in IBS patients.
• Antimicrobial therapy: Rifaximin, a non-absorbed antibiotic, protected the intestinal barrier from chemotherapy-induced damage in animal studies and preserved health-associated bacterial taxa.

One striking finding involved the bacterium Muribaculum intestinale. When researchers supplemented this single species in mice, it replicated the protective effects of rifaximin and reduced intestinal damage, even without changing overall gut microbiota composition. This suggests that specific bacterial strains, rather than broad microbial diversity alone, may be key to barrier repair.

How Does the Gut Microbiome Influence Brain and Behavior?

IBS patients experience high rates of psychiatric comorbidity, including anxiety and depression, but the mechanisms remain poorly understood. Recent research points to outer membrane vesicles (OMVs) produced by Gram-negative gut bacteria as a critical link between the microbiome and brain function. These vesicles are essential for bacterial survival but also communicate with the host in two distinct ways.

First, oral administration of OMVs increases blood-brain barrier permeability, allowing the vesicle contents, which include cytoplasmic molecules and DNA fragments, to enter the brain and alter brain chemistry and function. Second, OMVs activate the vagus nerve, the major communication highway between gut and brain, through toll-like receptors. However, researchers acknowledge significant limitations in current knowledge, including contamination risks, dose-relevance questions, and the gap between rodent studies and human disease.

What Is Auto-Brewery Syndrome and Why Should You Know About It?

Auto-brewery syndrome (ABS), also called gut fermentation syndrome, is a rare but increasingly recognized condition in which the gut microbiome produces ethanol internally. Improved diagnostic awareness has led to growing numbers of reported cases worldwide. The condition involves an altered microbiome with overgrowth of fermenting yeasts and certain bacterial taxa capable of producing alcohol.

Patients with ABS typically experience episodic neurocognitive and behavioral symptoms resembling alcohol intoxication, or chronic fatigue, cognitive impairment, and reduced quality of life. Diagnosis is challenging because it requires careful exclusion of external alcohol consumption. Management includes dietary sugar restriction, targeted antimicrobial or antifungal therapy, and correction of underlying predisposing factors.

What About Bile Acid Diarrhea as a Hidden IBS Mimic?

Bile acid diarrhea (BAD) is another condition frequently misdiagnosed as IBS. It should be considered in any child or adult presenting with chronic diarrhea or IBS with diarrhea, particularly when symptoms include postprandial diarrhea (diarrhea after eating), defecatory urgency, and episodes of fecal incontinence, once infectious and inflammatory causes are ruled out. Recent findings reveal that BAD is associated with a gut microbiome showing decreased expression of bile acid thiol ligase, an enzyme involved in transforming primary to secondary bile acids, and decreased sulfatases. These microbiome changes suggest that targeting specific bacterial taxa could offer future treatments for BAD.

The implications are significant: patients currently labeled with IBS may actually have BAD, endometriosis, post-infectious changes, or early-stage ovarian cancer. Microbiome research is revealing the biological differences between these conditions, offering hope for more accurate diagnosis and personalized treatment strategies based on individual gut bacterial profiles and barrier function.

" }